Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1452, 2004-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Somatropin provides long-term QOL improvement in GHD
Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. :
Neoadjuvant chemotherapy: long-term benefit in osteosarcoma
Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. :
Interferons in MS: long-term clinical benefit uncertain
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
Practical aspects of long-term treatment
By Malt U.F.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :